Suppression of hepatitis C virus replication by protein kinase C-related kinase 2 inhibitors that block phosphorylation of viral RNA polymerase.
about
Chaperones in hepatitis C virus infectionPhosphorylation of hepatitis C virus RNA polymerases ser29 and ser42 by protein kinase C-related kinase 2 regulates viral RNA replication.Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot.Myotonic dystrophy kinase-related Cdc42-binding kinases (MRCK), the ROCK-like effectors of Cdc42 and Rac1.Galactosylated Lipidoid Nanoparticles for Delivery of Small Interfering RNA to Inhibit Hepatitis C Viral Replication In Vivo.Enzyme kinetics and distinct modulation of the protein kinase N family of kinases by lipid activators and small molecule inhibitors.Identification of a resveratrol tetramer as a potent inhibitor of hepatitis C virus helicase.GRIM-19 Restricts HCV Replication by Attenuating Intracellular Lipid Accumulation.Interference of hepatitis C virus replication in cell culture by antisense peptide nucleic acids targeting the X-RNA.Regulation of the interaction between protein kinase C-related protein kinase 2 (PRK2) and its upstream kinase, 3-phosphoinositide-dependent protein kinase 1 (PDK1).Regulation of protein kinase C-related protein kinase 2 (PRK2) by an intermolecular PRK2-PRK2 interaction mediated by Its N-terminal domain.Mangosteen xanthones suppress hepatitis C virus genome replication.Inhibition of hepatitis C virus replication by Monascus pigment derivatives that interfere with viral RNA polymerase activity and the mevalonate biosynthesis pathway.HA1077 displays synergistic activity with daclatasvir against hepatitis C virus and suppresses the emergence of NS5A resistance-associated substitutions in mice
P2860
Q26771251-070C4FA5-056D-4CB6-B7BC-05B49C7FD4ACQ34261874-867B2F26-152F-41D3-A3B0-3C697DD6D58AQ35890093-295E7209-CCEA-4D4F-88D6-250D80F27C72Q36147000-3E4344F1-EC13-4E45-B968-D645F7B2D80EQ36172753-ABEC2C13-071C-4B06-B328-6BB935D12BADQ36213543-C8F4119E-A77B-484A-9D0A-EEBA83DCEEF9Q36744202-CD224F21-7ED8-4A46-9EC2-E2A1306A195FQ37747068-F6F79A25-94F2-4FF5-97D1-C47F0A0BF098Q38334100-17AFEE71-E90D-4EDB-BFDC-D16AE767C352Q39805182-22F240C3-4E0A-4672-95DF-215146CFD38EQ41858762-E23F72F5-6BE7-4DB0-ACFA-9167682EC32CQ42207865-724C79AE-FADC-4BA0-AF33-457B1BC23A6BQ43042322-572B7EC6-98F4-45AA-AA13-9CDC7FF62A91Q58737372-CED2ADF3-8D47-451D-997A-95AB7BF0D987
P2860
Suppression of hepatitis C virus replication by protein kinase C-related kinase 2 inhibitors that block phosphorylation of viral RNA polymerase.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Suppression of hepatitis C vir ...... ation of viral RNA polymerase.
@en
Suppression of hepatitis C vir ...... ation of viral RNA polymerase.
@nl
type
label
Suppression of hepatitis C vir ...... ation of viral RNA polymerase.
@en
Suppression of hepatitis C vir ...... ation of viral RNA polymerase.
@nl
prefLabel
Suppression of hepatitis C vir ...... ation of viral RNA polymerase.
@en
Suppression of hepatitis C vir ...... ation of viral RNA polymerase.
@nl
P2093
P2860
P1476
Suppression of hepatitis C vir ...... ation of viral RNA polymerase.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2893.2009.01108.X
P577
2009-02-23T00:00:00Z